Broker Willis Towers Watson will be broken up and large parts of it including a substantive part of its reinsurance operations sold to Arthur J. Gallagher & Co in a move designed to smooth the way for Aon’s acquisition of the business.
It is hoped the deal will help Aon secure a green light from concerned regulators. A number have expressed antitrust-related worries relating to the deal, most notably the European Commission. In April, the two brokers announced that they were developing a remedy proposal to alleviate these concerns.
The European Commission was reported to be on the verge of publishing a statement outlining all its fears. This prompted the firms to prepare a package of remedies designed to negate the need for this to be published at all.
Arthur J. Gallagher will acquire certain parts of Willis’s reinsurance, specialty, and retail brokerage operations in a US$3.5 billion deal expected to close during the second half of 2021.
The proposed deal is subject to European Commission, US Department of Justice, and other regulatory approvals, including regulatory approvals related to the pending Aon and Willis Towers Watson combination and the proposed remedy. That could mean the regulators may still have an important say on the future of all three businesses.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI